EarLy Treatment Response in nEoVascular Macular Degeneration With Eylea 8mg: ELEV8 A Prospective Observational Open Label Study Investigating the Fluid Dynamics During Early Response to Aflibercept 8mg in Patients With Exudative Age-related Macular Degeneration (AMD).
Clinical trial NCT07434713 · RECRUITING
Trial details
- NCT number
- NCT07434713
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-14
- Primary completion
- 2026-03-27
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.